As part of the 2022 Discovery Grant Program of the ALS Society of Canada and some Fondation Brain Canadawith the support of the Dr Jean-Pierre Canuel – ALS Quebec Fund, three research projects from the Faculty of Medicine of the University of Montreal have been selected to advance knowledge that will improve the diagnosis of lateral sclerosis amyotrophic disease (ALS) and the treatment of people living with this disease.
A total of nine Discovery Grants, worth more than $1.4 million, were awarded to multidisciplinary research teams from across Canada.
Here are the three UdeM Faculty of Medicine projects funded by the 2022 Discovery Grants.
Project: Could the study of neuromuscular junction proteins contribute to the development of essential biomarkers?
The Dr Richard Robitaille, Full Professor in the Department of Neurosciences at UdeM, in collaboration with the Dres Danielle Arbor and Roberta Piovesana, from the same department, and the Dr Robert Bowser of the Barrow Neurological Institute receives funding of $300,000.
Project: Could axon protection represent a promising treatment strategy for ALS?
The Dr Alex Parker, full professor in the Department of Neurosciences at UdeM and researcher at the CHUM Research Center, in collaboration with Dr.r Gary Armstrong of McGill University receives $300,000 in funding.
Project: What role does its sister protein play in restoring levels of G3BP1 as a potential ALS treatment strategy?
The Dre Christine Vande Velde, Full Professor in the Department of Neurosciences at UdeM and Researcher at the CHUM Research Center, in collaboration with Dr.re Marlene Oeffinger, associate professor in the University’s Department of Biochemistry and Molecular Medicine and researcher at the Montreal Clinical Research Institute, receives funding of $125,000.
Source: SLA Canada.